SET and MYND domain-containing protein 3 decreases sensitivity to dexamethasone and stimulates cell adhesion and migration in NIH3T3 cells (DOI:10.1263/jbb.103.444);SET and MYND domain-containing protein 3 decreases sensitivity to dexamethasone and stimulates cell adhesion and migration in NIH3T3 cells

Journal of Bioscience and Bioengineering

Volumn 103, Issue 5, 2007, Pages 444-450

  Luo, Xue Gang ^a   Ding, Yan ^a   Zhou, Qing Feng ^a   Ye, Liang ^a   Wang, Shu Zhen ^a   Xi, Tao ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

adhesion; dexamethasone; NIH3T3 cells; SET and MYND domain containing protein 3

Indexed keywords

BIOTECHNOLOGY; CELL ADHESION; CELL MEMBRANES; ENDOTHELIAL CELLS; ONCOLOGY; SENSITIVITY ANALYSIS;

CELL VIABILITY; DOWNSTREAM GENES; HUMAN CARCINOGENESIS;

ENZYMES;

COLLAGEN TYPE 4; DEXAMETHASONE; HISTONE METHYLTRANSFERASE; SMYD3 ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOLOGICAL ACTIVITY; CARCINOGENESIS; CELL ADHESION; CELL DEATH; CELL MIGRATION; CELL PROLIFERATION; CELL STRAIN 3T3; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBROBLAST; GENE OVEREXPRESSION; GENETIC TRANSFECTION; MOUSE; NONHUMAN; ONCOGENE; ONCOGENE C MYB; PROTEIN FUNCTION; TRANSCRIPTION REGULATION;

EID: 34250887512     PISSN: 13891723     EISSN: None     Source Type: Journal    
DOI: 10.1263/jbb.103.582     Document Type: Erratum

References (33)

1. Rodenhiser D., and Mann M. Epigenetics and human disease: translating basic biology into clinical applications. Can. Med. Assoc. J. 174 (2006) 341-348
2. Gibbons R.J. Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes. Hum. Mol. Genet. 14 (2005) R85-R92
3. Hamamoto R., Furukawa Y., Morita M., Ilimura Y., Silva F.P., Li M., Yagyu R., and Nakamura Y. SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells. Nat. Cell. Biol. 6 (2004) 731-740
4. Sims R.J., and Reinberg D. From chromatin to cancer: a new histone lysine methyltransferase enters the mix. Nat. Cell. Biol. 6 (2004) 685-687
5. Hamamoto R., Silva F.P., Tsuge M., Nishidate T., Katagiri T., Nakamura Y., and Furukawa Y. Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci. 97 (2006) 113-118
6. Schneider R., Bannister A.J., and Kouzarides T. Unsafe SETs: histone lysine methyltransferases and cancer. Trends Biochem. Sci. 27 (2002) 396-402
7. Spadaccini R., Perrin H., Bottomley M.J., Ansieau S., and Sattler M. Structure and functional analysis of the MYND Domain. J. Mol. Biol. 358 (2006) 498-508
8. Xu J.Y., Chen L.B., Xu J.Y., Yang Z., Wei H.Y., and Xu R.H. Suppression of SMYD3 expression in HepG2 cell by shRNA interference. Zhonghua Gan Zang Bing Za Zhi 14 (2006) 105-108
9. Xu J.Y., Chen L.B., Xu J.Y., Yang Z., Xu R.H., and Wei H.Y. Experimental research of therapeutic effect on hepatocellular carcinoma of targeting SMYD3 gene inhibition by RNA interference. Zhonghua Wai Ke Za Zhi 44 (2006) 481-484
10. Xu J.Y., Chen L.B., Xu J.Y., Yang Z., Wei H.Y., and Xu R.H. Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2. Ai Zheng 25 (2006) 526-532
11. Nesbit C.E., Grove L.E., Yin X., and Prochownik E.V. Differential apoptotic behaviors of c-myc, N-myc, and L-myc oncoproteins. Cell Growth Differ. 9 (1998) 731-741
12. Iwabuchi K., Nagaoka I., Someya A., and Yamashita T. Type IV collagen-binding proteins of neutrophils: possible involvement of L-selectin in the neutrophil binding to type IV collagen. Blood 87 (1996) 365-372
13. Ding Z., Issekutz T.B., Downey G.P., and Waddell T.K. L-selectin stimulation enhances functional expression of surface CXCR4 in lymphocytes: implications for cellular activation during adhesion and migration. Blood 101 (2003) 4245-4552
14. Qian F., Hanahan D., and Weissman I.L. l-Selectin can facilitate metastasis to lymph nodes in a transgenic mouse model of carcinogenesis. Proc. Natl. Acad. Sci. 98 (2001) 3976-3981
15. Thompson R.D., Noble K.E., Larbi K.Y., Dewar A., Duncan G.S., Mak T.W., and Nourshargh S. Platelet-endothelial cell adhesion molecule-1 (PECAM-1)-deficient mice demonstrate a transient and cytokine-specific role for PECAM-1 in leukocyte migration through the perivascular basement membrane. Blood 97 (2001) 1854-1860
16. Tang D.G., Chen Y.Q., Newman P.J., Shi L., Gao X., Diglio C.A., and Honn K.V. Identification of PECAM-1 in solid tumor cells and its potential involvement in tumor cell adhesion to endothelium. J. Biol. Chem. 268 (1993) 22883-22894
17. Huflejt M.E., Jordan E.T., Gitt M.A., Barondes S.H., and Leffler H. Strikingly different localization of galectin-3 and galectin-4 in human colon adenocarcinoma T84 cells. Galectin-4 is localized at sites of cell adhesion. J. Biol. Chem. 272 (1997) 14294-14303
18. Huflejt M.E., and Leffler H. Galectin-4 in normal tissues and cancer. Glycoconjugate J. 20 (2004) 247-255
19. Uemura N., Salgia R., Ewaniuk D.S., Little M.T., and Griffin J.D. Involvement of the adapter protein CRKL in integrin-mediated adhesion. Oncogene 18 (1999) 3343-3353
20. Li L., Guris D.L., Okura M., and Imamoto A. Translocation of CrkL to focal adhesions mediates integrin-induced migration downstream of Src family kinases. Mol. Cell. Biol. 23 (2003) 2883-2892
21. Brodeur G.M., Seeger R.C., Schwab M., Varmus H.E., and Bishop J.M. Amplification of N-myc in untreated human with neuroblastomas correlates advanced disease stage. Science 224 (1984) 1121-1124
22. Meitar D., Crawford S.E., Rademaker A.W., and Cohn S.L. Tumor angiogenesis correlates with metastatic disease, N-myc amplification, and poor outcome in human neuroblastoma. J. Clin. Oncol. 14 (1996) 405-414
23. Néstor T., Masckauchán H., and Kitajewski J. Wnt/Frizzled signaling in the vasculature: new angiogenic factors in sight. Physiology 21 (2006) 181-188
24. Sambrook J., and Russell D.W. Molecular cloning: a laboratory manual. 3rd ed. (2002), Cold Spring Harbor Laboratory Press, New York
25. Kozak M. Structural features in eukaryotic mRNAs that modulate the initiation of translation. J. Biol. Chem. 266 (1991) 19867-19870
26. Herren B., Garton K.J., Coats S., Bowen-Pope D.F., Ross R., and Raines E.W. ADAM15 overexpression in NIH3T3 cells enhances cell-cell interactions. Exp. Cell. Res. 271 (2001) 152-160
27. Sato S., Ouellet N., Pelletier I., Simard M., Rancourt A., and Bergeron M.G. Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. J. Immunol. 168 (2002) 1813-1822
28. Nakayama M., Amano M., Katsumi A., Kaneko T., Kawabata S., Takefuji M., and Kaibuchi K. Rho-kinase and myosin II activities are required for cell type and environment specific migration. Genes Cells 10 (2005) 107-117
29. Frank B., and Serrano M. Tumor suppressors and oncogenes in cellular senescence. Exp. Gerontol. 35 (2000) 317-329
30. Cooper G.M. Cellular transforming genes. Science 218 (1982) 801-806
31. Lauffenburger D.A., and Horwitz A.F. Cell migration: a physically integrated molecular process. Cell 84 (1996) 359-369
32. Teti A. Regulation of cellular functions by extracellular matrix. J. Am. Soc. Nephrol. 2 (1992) S83-S87
33. Olivero D.K., and Furcht L.T. Type IV collagen, laminin, and fibronectin promote the adhesion and migration of rabbit lens epithelial cells in vitro. Invest. Ophthalmol. Vis. Sci. 34 (1993) 2825-2834